Počet záznamov: 1
apolipoproteín C-I
SYS d053302 LBL 00000nx--j22000003--45-- 005 20240119200545.2 100 $a 20060705csloy0103----ba0 152 $b mesh 250 $a apolipoproteín C-I $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2007; use APOLIPOPROTEIN C-I (NM) 1979-2006 $8 eng 300 1-
$a Apolipoproteins C (1977-2006) $8 eng 330 1-
$a A 6.6-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS; INTERMEDIATE-DENSITY LIPOPROTEINS; and HIGH-DENSITY LIPOPROTEINS. Apo C-I displaces APO E from lipoproteins, modulate their binding to receptors (RECEPTORS, LDL), and thereby decrease their clearance from plasma. Elevated Apo C-I levels are associated with HYPERLIPOPROTEINEMIA and ATHEROSCLEROSIS. $8 eng 686 $a D10.532.091.400.500 686 $a D12.776.070.400.400.500 686 $a D12.776.521.120.400.500 750 $a Apolipoprotein C-I $8 eng 801 -0
$a US $b DNLM $c 20060705 801 -2
$a SK $b BA006 $c 20070109 980 $x M
Počet záznamov: 1